Newstral
Article
jdsupra.com on 2022-05-06 18:38
OIG Issues Advisory Opinion Approving Biopharmaceutical Manufacturer’s Sponsorship of Free Genetic Testing and Counseling
Related news
- OIG Issues Favorable Advisory Opinion Regarding Biopharmaceutical Company Arrangement to Provide Free Genetic Testing and Counseling to Potentially Eligible Patientsjdsupra.com
- OIG Approves Manufacturer’s Offer of Free Genetic Testingjdsupra.com
- OIG Permits Medical Device Manufacturer’s Cost-Sharing Subsidies for Medicare Beneficiaries in Clinical Trialjdsupra.com
- OIG Determines a Drug Manufacturer’s Initiative to Cover Certain Patients’ Transportation Costs Poses Low Risk of Fraud and Abusejdsupra.com
- OIG Greenlights Manufacturer’s Limited Free Drug Programjdsupra.com
- OIG Issues Favorable Advisory Opinion for Free Genetic Testing and Counseling Program Offered by a Pharmaceutical Companyjdsupra.com
- Prominent German Artists Object to Arms Manufacturer’s Exhibition Sponsorshiphyperallergic.com
- OIG Issues Advisory Opinion Approving Supermarket Pharmacy Loyalty Programjdsupra.com
- OIG Approves Pharmaceutical Manufacturer’s Loaning of Smartphones to Support Digital Medicine (DM)jdsupra.com
- OIG Issues Advisory Opinion for Pharmaceutical Manufacturer’s Cost-Sharing Assistance Proposaljdsupra.com
- HHS-OIG: Pharma Manufacturer’s Proposed Copayment Assistance Program ‘Highly Suspect’ Under Federal Anti-Kickback Statutejdsupra.com
- OIG Advisory Opinion Rejects Pharmaceutical Manufacturer’s Proposed Beneficiary Cost-Sharing Programjdsupra.com
- OIG Declines to Impose Sanctions Against Device Manufacturer’s Medicare Cost-Sharing Subsidy in Clinical Trialjdsupra.com
- OIG Issues Favorable Advisory Opinion Involving an Arrangement With 0% Financing Options for a DME Manufacturer’s Customersjdsupra.com
- OIG Issues Four Advisory Opinionsjdsupra.com
- Free Medicare counseling sessionstheridgefieldpress.com
- EHICAP INSURANCE COUNSELINGeccalifornian.com
- OIG Issues Advisory Opinion Giving the Green Light to a Pharmaceutical Manufacturer’s Plan to Provide Limited Functionality Smartphones to Financially Needy Patients for Adherence Data Monitoringjdsupra.com
- OIG Issues Favorable Advisory Opinion on a Drug Manufacturer’s Provision to Hospitals of Trial Units of Antipsychotic Medication for Inpatient Usejdsupra.com
- OIG Reaffirms Permissibility of Certain Gainsharing Arrangementsjdsupra.com